Piramal Enterprises is still a Kamadhenu of the Indian Stock Market. Updates on the end of the Financial year.
Read More
Demonetization triggers Piramal Enterprise’s first ConCall in years !
Whenever there is wild spread ambiguity, i remember Pabrai’s distinction between risk and uncertainty loud and clear. In this specific case, the loan book concerns were about mortgage worthiness (risk) and cash flow/interest payments (uncertainty ). Piramal seems to have put off taking calls from investors all these years as the entire group structure itself…
Read MoreWhy Ajay Piramal does not want you to read the Standalone Statements. (and other updates from the 2015 AGM)
I was suddenly taken aback when Ajay Piramal said this, ” Please do not read the standalone statements and read only the consolidated statements. If you do so you will only be wasting your time.” Â While my CA instincts kicked in all i wanted to do was hold up a red flag, but then this…
Read More
Piramal’s definitive 3 pronged approach.
I initially bought into Piramal Healthcare as it was a cash bargain. At 360/- a share you actually got over 600/- of cash ( ignoring all the irrelevant stuff like management, brand company history etc 🙂 ). The logic was that even if Ajay Piramal lost/mismanaged or stole 50% of the cash, my investment would…
Read MorePiramal Enterprises – Q3 Note
Q3 in cr Pharma and Manufacturing Financial Services Information Management Unallocated Total Capital Employed 3221 9202 4293 (4607) 12110 Revenue 802 219 377 1398 Profits as reported -5 162 132 47 346 Profits without exceptional -5-2+34-18=9 162 132 47 350 Finance Cost -95 PBT 241 The Pharma and Manufacturing business has finally turned cash positive,…
Read MorePiramal Enterprises – 2014 AGM update
When i walked into the PEL AGM it seemed like an ultra simple affair without much hoo-hah, until i looked at the Board. The best of the best were patiently sitting there. Â Ajay, Swati and Nandini Piramal, Keki Dadiseth, N.Vaghul, and Ramadorai amongst others i couldn’t recognise. Partly intimidating, but mostly gratifying. Despite the big…
Read MorePiramal Enterprises FY2014 – The Genius Partly Revealed
While the Media has been focusing merely on Piramal’s cash pile, and have rather been supremely obsessive about it, Ajay Piramal has had most of his investments show green shoots already. From approval of 2 drugs by the USFDA and the EU and IndiaREIT growing to manage over 7,500cr the media has missed a lot…
Read MorePiramal Enterprises – FDA Approves Florbetaben
Piramal Imaging ( Subsidiary of Piramal Enterprises) has made two major acquisitions, BST CarGel for 30cr in 2011 from BioSynTech and a molecular imaging Portfolio from Bayer in 2012 for an undisclosed amount. CarGel received approval in the EU in 2012 and is still awaiting approval from the FDA. For an acquisition price of 30cr…
Read MorePiramal Enterprises – Awaiting a PE re-rating
Instead of a little footnote at the bottom of my post saying that i’m an interested party, I’d like to begin by saying that i’m totally interested in Piramal Enterprises and an ardent admirer of Ajay.G.Piramal. I bought into the company at Rs 360 when a back of the envelope calculation reveiled cash per share…
Read More